Budúce P/E spoločnosti Acasti Pharma Inc

Aká je hodnota metriky Budúce P/E spoločnosti Acasti Pharma Inc?

Hodnota metriky Budúce P/E spoločnosti Acasti Pharma Inc je -3.61

Aká je definícia metriky Budúce P/E?

Budúci pomer P/E (Forward price to earnings ratio) vyjadruje pomer súčasnej ceny a odhadovaného zisku na akciu za ďalších 12 mesiacov.

The forward price to earnings ratio is similar to trailing price to earnings ratio but instead of net income uses estimated net earnings over next 12 months. Estimates are typically derived as the mean of those published by a select group of analysts with selection criteria varying. The forward price-to-earnings ratio is a powerful, but limited tool. It allows a quick snapshot of the company’s finances without getting down in the details of an accounting report.

Čomu sa venuje spoločnosť Acasti Pharma Inc?

acasti pharma, inc., a subsiduary of neptune technologies & bioressources, is a quebec-based biopharmaceutical dedicated in advancing a proprietary portfolio based on marine phospholipids. our products can be used in prescription, medical food and over-the-counter applications, either as a stand-alone, or, as a fixed-dose combination to exisitng productrs, for the prevention and treatment of cardiometabolic disorders.

Firmy s metrikou budúce p/e podobnou spoločnosti Acasti Pharma Inc